AI-powered platform simplifying clinical trial data for retail biotech investors.
What is bioPulse?
bioPulse uses AI technology to turn complex clinical trial data into summaries and insights that are easy for retail biotech investors to understand. It transforms complex clinical trial data and biotech news into clear, actionable summaries, helping investors spot investment opportunities faster.
How do I use bioPulse?
Join the beta testing waitlist for early access. Once you’re in, use the platform to access AI-powered summaries and insights on clinical trial data and biotech news. Analyze data, review SEC filings, and assess the competitive landscape.
bioPulse's core features
AI-Based Clinical Trial Summary
Market Impact Analysis
Real-time alerts for biotech news and trial results
SEC Filing Analysis
Competitive Landscape Analysis